StonvexLoading…
StonvexStonvexStonvexCore line items from MDRR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $10.40M | $7.57M | $4.79M | $2.32M |
Operating Income | $547.90K | $68.29K | $-373.23K | $-552.52K |
Net Income | $-2.39M | $-1.92M | $-1.53M | $-1.01M |
EPS (Diluted) | $-1.90 | $-1.47 | $-1.13 | $-0.74 |
Total Assets | $77.74M | $92.10M | $77.66M | $78.23M |
Total Liabilities | $53.63M | $67.11M | $52.34M | $52.38M |
Cash & Equivalents | $2.63M | $1.89M | $1.95M | $2.74M |
Free Cash Flow OCF − CapEx | $76.99K | $1.14M | $140.88K | $322.38K |
Shares Outstanding | 1.11M | 1.11M | 1.35M | 1.36M |